Loading clinical trials...
Loading clinical trials...
This exploratory study aims to evaluate the diagnostic, prognostic and response predictive value of a multi biomarker strategy in patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ipsen
NCT07165886 · Gastroenteropancreatic Neuroendocrine Tumors
NCT01842165 · Gastroenteropancreatic Neuroendocrine Tumors
NCT01747096 · Patients With Gastroenteropancreatic Neuroendocrine Tumors
NCT02231762 · Gastroenteropancreatic Neuroendocrine Tumors
NCT02078843 · Gastroenteropancreatic Neuroendocrine Tumors
Aarhus
Copenhagen
Odense
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions